Literature DB >> 30850536

Crystal structure of human mitochondrial trifunctional protein, a fatty acid β-oxidation metabolon.

Chuanwu Xia1, Zhuji Fu1, Kevin P Battaile2, Jung-Ja P Kim3.   

Abstract

Membrane-bound mitochondrial trifunctional protein (TFP) catalyzes β-oxidation of long chain fatty acyl-CoAs, employing 2-enoyl-CoA hydratase (ECH), 3-hydroxyl-CoA dehydrogenase (HAD), and 3-ketothiolase (KT) activities consecutively. Inherited deficiency of TFP is a recessive genetic disease, manifesting in hypoketotic hypoglycemia, cardiomyopathy, and sudden death. We have determined the crystal structure of human TFP at 3.6-Å resolution. The biological unit of the protein is α2β2 The overall structure of the heterotetramer is the same as that observed by cryo-EM methods. The two β-subunits make a tightly bound homodimer at the center, and two α-subunits are bound to each side of the β2 dimer, creating an arc, which binds on its concave side to the mitochondrial innermembrane. The catalytic residues in all three active sites are arranged similarly to those of the corresponding, soluble monofunctional enzymes. A structure-based, substrate channeling pathway from the ECH active site to the HAD and KT sites is proposed. The passage from the ECH site to the HAD site is similar to those found in the two bacterial TFPs. However, the passage from the HAD site to the KT site is unique in that the acyl-CoA intermediate can be transferred between the two sites by passing along the mitochondrial inner membrane using the hydrophobic nature of the acyl chain. The 3'-AMP-PPi moiety is guided by the positively charged residues located along the "ceiling" of the channel, suggesting that membrane integrity is an essential part of the channel and is required for the activity of the enzyme.

Entities:  

Keywords:  fatty acid oxidation; metabolon; mitochondrial trifunctional protein; substrate channeling

Mesh:

Substances:

Year:  2019        PMID: 30850536      PMCID: PMC6442613          DOI: 10.1073/pnas.1816317116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  The CCP4 suite: programs for protein crystallography.

Authors: 
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1994-09-01

2.  Novel fatty acid beta-oxidation enzymes in rat liver mitochondria. II. Purification and properties of enoyl-coenzyme A (CoA) hydratase/3-hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase trifunctional protein.

Authors:  Y Uchida; K Izai; T Orii; T Hashimoto
Journal:  J Biol Chem       Date:  1992-01-15       Impact factor: 5.157

Review 3.  Complexes of sequential metabolic enzymes.

Authors:  P A Srere
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

4.  Common missense mutation G1528C in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Characterization and expression of the mutant protein, mutation analysis on genomic DNA and chromosomal localization of the mitochondrial trifunctional protein alpha subunit gene.

Authors:  L IJlst; J P Ruiter; J M Hoovers; M E Jakobs; R J Wanders
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

5.  Analysis of the structure, substrate specificity, and mechanism of squash glycerol-3-phosphate (1)-acyltransferase.

Authors:  A P Turnbull; J B Rafferty; S E Sedelnikova; A R Slabas; T P Schierer; J T Kroon; J W Simon; T Fawcett; I Nishida; N Murata; D W Rice
Journal:  Structure       Date:  2001-05-09       Impact factor: 5.006

6.  Glutamate 170 of human l-3-hydroxyacyl-CoA dehydrogenase is required for proper orientation of the catalytic histidine and structural integrity of the enzyme.

Authors:  J J Barycki; L K O'Brien; A W Strauss; L J Banaszak
Journal:  J Biol Chem       Date:  2001-07-12       Impact factor: 5.157

Review 7.  The mitochondrial trifunctional protein: centre of a beta-oxidation metabolon?

Authors:  S Eaton; T Bursby; B Middleton; M Pourfarzam; K Mills; A W Johnson; K Bartlett
Journal:  Biochem Soc Trans       Date:  2000-02       Impact factor: 5.407

8.  Structural and functional characterization of the recombinant human mitochondrial trifunctional protein.

Authors:  Benjamin Fould; Virginie Garlatti; Emmanuelle Neumann; Daphna Fenel; Christine Gaboriaud; Gérard J Arlaud
Journal:  Biochemistry       Date:  2010-09-08       Impact factor: 3.162

9.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

10.  General mitochondrial trifunctional protein (TFP) deficiency as a result of either alpha- or beta-subunit mutations exhibits similar phenotypes because mutations in either subunit alter TFP complex expression and subunit turnover.

Authors:  Ute Spiekerkoetter; Zaza Khuchua; Zou Yue; Michael J Bennett; Arnold W Strauss
Journal:  Pediatr Res       Date:  2003-11-19       Impact factor: 3.756

View more
  20 in total

1.  Mitochondrial fatty acid oxidation and the electron transport chain comprise a multifunctional mitochondrial protein complex.

Authors:  Yudong Wang; Johan Palmfeldt; Niels Gregersen; Alexander M Makhov; James F Conway; Meicheng Wang; Stephen P McCalley; Shrabani Basu; Hana Alharbi; Claudette St Croix; Michael J Calderon; Simon Watkins; Jerry Vockley
Journal:  J Biol Chem       Date:  2019-06-24       Impact factor: 5.157

2.  Mitochondrial protein interaction landscape of SS-31.

Authors:  Juan D Chavez; Xiaoting Tang; Matthew D Campbell; Gustavo Reyes; Philip A Kramer; Rudy Stuppard; Andrew Keller; Huiliang Zhang; Peter S Rabinovitch; David J Marcinek; James E Bruce
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-17       Impact factor: 11.205

Review 3.  A "Weird" Mitochondrial Fatty Acid Oxidation as a Metabolic "Secret" of Cancer.

Authors:  Zhivko Zhelev; Ichio Aoki; Dessislava Lazarova; Tatyana Vlaykova; Tatsuya Higashi; Rumiana Bakalova
Journal:  Oxid Med Cell Longev       Date:  2022-02-08       Impact factor: 6.543

4.  An Altered Sphingolipid Profile as a Risk Factor for Progressive Neurodegeneration in Long-Chain 3-Hydroxyacyl-CoA Deficiency (LCHADD).

Authors:  Sara Tucci
Journal:  Int J Mol Sci       Date:  2022-06-27       Impact factor: 6.208

5.  UBE2O promotes lipid metabolic reprogramming and liver cancer progression by mediating HADHA ubiquitination.

Authors:  Meilin Ma; Changhui Zhang; Rong Cao; Dongmei Tang; Xiongbo Sang; Sailan Zou; Xiuxuan Wang; Haixia Xu; Geng Liu; Lunzhi Dai; Yan Tian; Xiang Gao; Xianghui Fu
Journal:  Oncogene       Date:  2022-10-22       Impact factor: 8.756

Review 6.  Proteolytic Control of Lipid Metabolism.

Authors:  Pingdewinde N Sam; Erica Avery; Steven M Claypool
Journal:  ACS Chem Biol       Date:  2019-09-30       Impact factor: 5.100

Review 7.  Monolysocardiolipin (MLCL) interactions with mitochondrial membrane proteins.

Authors:  Anna L Duncan
Journal:  Biochem Soc Trans       Date:  2020-06-30       Impact factor: 5.407

8.  TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes.

Authors:  Jason W Miklas; Elisa Clark; Shiri Levy; Damien Detraux; Andrea Leonard; Kevin Beussman; Megan R Showalter; Alec T Smith; Peter Hofsteen; Xiulan Yang; Jesse Macadangdang; Tuula Manninen; Daniel Raftery; Anup Madan; Anu Suomalainen; Deok-Ho Kim; Charles E Murry; Oliver Fiehn; Nathan J Sniadecki; Yuliang Wang; Hannele Ruohola-Baker
Journal:  Nat Commun       Date:  2019-10-11       Impact factor: 14.919

9.  Anti-Fatigue Activity of a Mixture of Stauntonia hexaphylla (Thunb.) Decaisne and Vaccinium bracteatum Thunb. Fruit Extract.

Authors:  Joohyun Oh; Yoonyoung Han; Jimin Kim; Chansung Park; Doolri Oh; Hyojeong Yun; Gyuok Lee; Jaeyong Kim; Chulyung Choi; Yongwook Lee
Journal:  Prev Nutr Food Sci       Date:  2020-12-31

10.  Physiological Perspectives on the Use of Triheptanoin as Anaplerotic Therapy for Long Chain Fatty Acid Oxidation Disorders.

Authors:  Evgenia Sklirou; Ahmad N Alodaib; Steven F Dobrowolski; Al-Walid A Mohsen; Jerry Vockley
Journal:  Front Genet       Date:  2021-01-15       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.